期刊文献+

分枝杆菌同源可控表达系统的建立及其应用 被引量:2

Development of mycobacterial inducible expression system and application for immunological diagnostics on tuberculosis
原文传递
导出
摘要 目的构建分枝杆菌可控表达载体,利用其过表达结核分枝杆菌(Mycobacterium tuberculosis,Mtb)的免疫保护性抗原,亲和层析纯化后分析免疫原性。方法应用PCR扩增耻垢分枝杆菌(Mycobacterium smegmatis,Ms)乙酰胺酶编码基因启动子(pACE),构建分枝杆菌可控表达载体pMF系列;克隆Mtb嵌合抗原编码基因并用乙酰胺进行诱导表达,以Ni^2+亲和层析纯化重组蛋白;并用该重组嵌合抗原Ag856 A2对卡介苗(BCG)免疫的小鼠脾细胞进行体外刺激,以IFN-γ酶联免疫斑点技术(ELISPOT)分析其免疫原性。结果成功构建了分枝杆菌可控表达载体pMF系列,利用0.02%乙酰胺进行诱导可实现目标抗原在Ms中的高水平表达;同时利用引入的6×Ilis标签可方便实现重组抗原的一步纯化,且该同源表达重组抗原可诱导更高水平IFN-γ的分泌。结论以Ms乙酰胺酶编码基因启动子pACE为基础构建的分枝杆菌可控表达系统可实现Mtb抗原在Ms中的高水平表达与纯化,与大肠杆菌异源表达相比,该同源表达重组抗原具有更好的免疫原性。 Objective To develop mycobaeterial inducible expression vectors which permit to overexpress Mycobacterium tuberculosis (Mtb) immunodomlnant antigen, and to analyze its immunogenicity after purification by affinity chromatography. Methods The regulatory region of M. smegmatis(Ms) acetamidase(pACE) was obtained by PCR amplification, and was used as promoter to construct the mycobacterial inducible expression vectors, pMF series. The coding gene of Mtb chimeric antigen Ag856A2 which is a recombinant Ag85A with 2 copies of ESAT-6 inserted in its Ace I site and showed excellent immunogenicity in the animal experiments we described previously, was eloned into the pMF vector series, and was induced to express by the addition of acetamide. The recombinant protein expressed in the Ms was purified by the Ni2^+ -NTA affinity chromatography, the resulted homologous recombinant antigen was added into the spleen cells separated from BCG vaccinated mice, and the immunogenicity was analyzed by the IFN-3, ELISPOT assay. Results The mycobacterial inducible expression vectors, pMF series was constructed successfully, target antigen could be induced to express in the Ms by the addition of 0.02% acetamide, and could be purified by the Ni2^+ -NTA affinity chromatography due to the addition of 6 × His tag in the vector pMF406. Furthennore, the mycobacterial homologous antigen could induce more IFN-γ secretion than the heterogonous one. Conclusion The mycobacterial inducible expression system based on the regulatory region of Ms acetamidase as promoter could permit the Mtb target antigen of interest overexpression and purification, and the immunogenicity of the homologous antigen from Ms is better than that of be expressed from E. coli, which may be more potential for immunological detection of tuberculosis.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2009年第12期1104-1109,共6页 Chinese Journal of Microbiology and Immunology
基金 国家“十一五”重大传染病专项(2008ZX10003011) 上海市青年科技启明星计划(09QA1405200) 国家自然科学基金资助项目(30901276)
关键词 分枝杆菌 乙酰胺酶 启动子 同源表达 可诱导表达 Mycobacteria Acetamidase Promoter Homologous expression Inducible expression
  • 相关文献

参考文献19

  • 1Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 1998, 393(6685): 537-544.
  • 2Mulder MA, Zappe H, Steyn LM. Mycobactefial promoters. Tuber Lung Dis, 1997, 78(5-6) : 211-223.
  • 3Griffiths E. Environmental regulation of bacterial virulence-implications for vaccine design and production. Trends Biotechnol, 1991, 9(9) : 309-315.
  • 4Storz G, Tartaglia LA, Farr SB, et al. Bacterial defenses against oxidative stress. Trends Genet, 1990, 6 ( 11 ) : 363-368.
  • 5Roberts G, Muttucumaru DG, Parish T. Control of the acetamidase gene of Mycobacterium smegmatis by multiple regulators. FEMS Microbiol Lett, 2003, 221 ( 1 ) : 131-136.
  • 6Li Z, Song D, Zhang H, et al. Improved humoral immunity against tuberculosis ESAT-6 antigen by chimeric DNA prime and protein boost strategy. DNA Cell Biol, 2006, 25 ( 1 ) : 25-30.
  • 7Fan XY, Ma H, Guo J, et al. A novel differential expression system for gene modulation in Mycobacteria. Plasmid, 2009, 61 ( 1 ) : 39-46.
  • 8Parish T, Mahenthiralingam E, Draper P, et al. Regulation of the inducible acetamidase gene of Mycobacterium smegmatis. Microbiology, 1997, 143 (Pt 7) : 2267-2276.
  • 9Parish T, Turner J, Stoker NG. amiA is a negative regulator of acetamidase expression in Mycobacterium smegmatis. BMC Microbiol, 2001, 1: 19.
  • 10Parish T, Stoker NG. Development and use of a conditional antisense mutagenesis system in Mycobacteria. FEMS Microbial Lett, 1997, 154(1): 151-157.

同被引文献22

  • 1Brewer TF, Colditz GA. Relationship between baeille Calmette-Guerin (BCG) strains and the efficacy of BCG vaccine in the pre- vention of tuberculosis. Clin Infect Dis, 1995,20 (1) : 126-135.
  • 2Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vac- cine in the prevention of tuberculosis. Meta-analysis of the pub- lished literature. JAMA, 1994, 271 (9) : 698-702.
  • 3Cockle PJ, Gordon SV, Lalvani A, et al. Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic re- agents or subunit vaccine candidates by comparative genomios. In- fect Immun, 2002, 70(12): 6996-7003.
  • 4Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole-genome DNA mieroarray. Science, 1999, 284(5419) : 1520-1523.
  • 5Yi WC, Hsiao S, Liu JH, et al. Use of fluorescein labelled anti- body and fluorescence activated cell sorter for rapid identification of Mycobacterium species. Biochem Biophys Res Commun, 1998, 250(2) : 403-408.
  • 6Rowland B, Purkayastha A, Monserrat C, et al. Fluorescence- based detection of laeZ reporter gene expression in intact and via- ble bacteria including Mycobacterium species. FEMS Microbiol Lett, 1999, 179(2) : 317-325.
  • 7Pina-Vaz C, Costa-de-Oliveira S, Rodrigues AG. Safe suseeptibil-ity testing of Mycobacterium tuberculosis by flow cytometry with thefluorescent nucleic acid stain SYTO 16. J Med Microbiol, 2005,54(Pt 1) : 77-81.
  • 8Yu JS, Whitesides J, I.ee SH, et al. Flow cytometty sorting of re-combinant mycobacterial species yields bacterial clones with en-hanced insert expression. Clin Vaccine Immunol, 2011, 18(1) :43-49.
  • 9Dietrich G, Viret JF, Hess J. Novel vaccination strategies based on recombinant Mycobacterium boris BCG. Int J Med Microbiol, 2003, 292(7-8): 441-451.
  • 10Dietrich G, Viret JF, Hess J. Myeobactedum botis BCG-based vaccines against tuberculosis: novel developments. Vaccine, 2003, 21 (7-8): 667-670.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部